HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zsuzsanna Kahán Selected Research

Noninfiltrating Intraductal Carcinoma (DCIS)

1/2022Radiotherapy of Breast Cancer-Professional Guideline 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.
12/2020[4th Hungarian Breast Cancer Consensus Conference - Radiotherapy guidelines].
1/2016[3rd Hungarian Breast Cancer Consensus Conference - Radiotherapy Guidelines].
9/2008[Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
6/2008The role of radiotherapy in the conservative treatment of ductal carcinoma in situ of the breast.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zsuzsanna Kahán Research Topics

Disease

39Breast Neoplasms (Breast Cancer)
01/2022 - 03/2003
25Neoplasms (Cancer)
01/2022 - 03/2003
5Neoplasm Metastasis (Metastasis)
01/2022 - 01/2013
5Noninfiltrating Intraductal Carcinoma (DCIS)
01/2022 - 06/2008
4Renal Cell Carcinoma (Grawitz Tumor)
01/2019 - 03/2014
3Heart Diseases (Heart Disease)
11/2021 - 10/2016
2Heart Failure
11/2021 - 04/2018
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
11/2021 - 04/2018
2Fibrosis (Cirrhosis)
11/2021 - 07/2011
2Prostatic Neoplasms (Prostate Cancer)
03/2020 - 07/2019
2Pancreatic Neoplasms (Pancreatic Cancer)
03/2020 - 04/2016
2Carcinoma (Carcinomatosis)
03/2020 - 09/2014
2Neutropenia
06/2019 - 09/2016
2Stomatitis
01/2019 - 03/2014
2Exanthema (Rash)
01/2019 - 03/2014
2Anemia
01/2019 - 03/2014
2Edema (Dropsy)
01/2019 - 03/2014
2Disease Progression
01/2018 - 09/2016
2Hypertension (High Blood Pressure)
09/2016 - 09/2015
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2013 - 04/2011
1Hodgkin Disease (Hodgkin's Disease)
04/2021
1Esophageal Neoplasms (Esophageal Cancer)
04/2021
1Pathologic Complete Response
01/2021
1Ovarian Neoplasms (Ovarian Cancer)
03/2020
1DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
03/2020
1Sarcoma (Soft Tissue Sarcoma)
03/2020
1Hypertrophy
01/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2018
1Multiple Sclerosis
04/2018
1Myocardial Infarction
04/2018
1Diabetic Nephropathies (Diabetic Nephropathy)
04/2018
1Schizophrenia (Dementia Praecox)
04/2018
1Inflammation (Inflammations)
04/2018
1Diabetes Mellitus
04/2018
1Brain Neoplasms (Brain Tumor)
04/2018
1Brain Ischemia (Cerebral Ischemia)
04/2018
1Asthma (Bronchial Asthma)
04/2018
1Liver Neoplasms (Liver Cancer)
04/2018
1Reperfusion Injury
04/2018

Drug/Important Bio-Agent (IBA)

10Hormones (Hormone)IBA
01/2018 - 04/2005
5Estrogen ReceptorsIBA
01/2018 - 03/2003
5Biological ProductsIBA
01/2012 - 06/2008
4Trastuzumab (Herceptin)FDA Link
01/2021 - 01/2007
4AnthracyclinesIBA
01/2018 - 01/2009
4Paclitaxel (Taxol)FDA LinkGeneric
09/2016 - 01/2010
3Proteins (Proteins, Gene)FDA Link
11/2021 - 06/2010
3Capecitabine (Xeloda)FDA Link
07/2017 - 01/2011
2SolutionsIBA
01/2022 - 12/2020
2DNA (Deoxyribonucleic Acid)IBA
07/2021 - 03/2020
2Tumor Biomarkers (Tumor Markers)IBA
12/2020 - 01/2016
2EverolimusFDA Link
01/2019 - 03/2014
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2019 - 03/2014
2Tyrosine Kinase InhibitorsIBA
01/2019 - 03/2014
2CalciumIBA
04/2018 - 01/2013
2Sunitinib (Sutent)FDA Link
01/2018 - 09/2014
2Estrogen Receptor Modulators (Antiestrogen)IBA
01/2018 - 03/2003
2Docetaxel (Taxotere)FDA Link
07/2017 - 01/2011
2ErbB Receptors (EGF Receptor)IBA
09/2015 - 06/2010
2Estrogens (Estrogen)FDA Link
01/2013 - 04/2005
2human ERBB2 proteinIBA
01/2012 - 01/2011
2Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2012 - 01/2011
2TamoxifenFDA LinkGeneric
07/2011 - 03/2003
2Epirubicin (Ellence)FDA LinkGeneric
01/2011 - 12/2008
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2008 - 04/2005
2Progesterone Receptors (Progesterone Receptor)IBA
06/2008 - 07/2006
1Transforming Growth Factor beta (TGF-beta)IBA
11/2021
1Connective Tissue Growth FactorIBA
11/2021
1Chymases (Chymase)IBA
11/2021
1Losartan (Cozaar)FDA LinkGeneric
11/2021
1Angiotensin Receptor AntagonistsIBA
11/2021
1Circulating Tumor DNAIBA
07/2021
1pertuzumabIBA
01/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
03/2020
1PlatinumIBA
03/2020
1Biosimilar PharmaceuticalsIBA
06/2019
1pegfilgrastim (Neulasta)FDA Link
06/2019
1Sirtuin 1IBA
01/2019
1MEF2 Transcription FactorsIBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA
01/2019
1TensinsIBA
01/2019
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2019
1CalcineurinIBA
01/2019
1HSP40 Heat-Shock ProteinsIBA
01/2019
1Messenger RNA (mRNA)IBA
01/2019
1AMP-Activated Protein KinasesIBA
01/2019
1MicroRNAs (MicroRNA)IBA
04/2018
1Fulvestrant (Faslodex)FDA Link
01/2018

Therapy/Procedure

28Therapeutics
01/2022 - 01/2004
20Radiotherapy
01/2022 - 05/2007
14Drug Therapy (Chemotherapy)
01/2021 - 06/2008
9Segmental Mastectomy (Lumpectomy)
01/2022 - 06/2008
6Neoadjuvant Therapy
07/2021 - 01/2009
6Conformal Radiotherapy
01/2014 - 05/2007
2Chemoradiotherapy
04/2013 - 04/2011
2Adjuvant Chemotherapy
01/2012 - 12/2008
2Chemoprevention
07/2006 - 03/2003
1Palliative Care (Palliative Therapy)
07/2021
1Nephrectomy
01/2018
1Combined Modality Therapy
01/2018